Amyloid-independent atrophy patterns predict time to progression to dementia in mild cognitive impairment
暂无分享,去创建一个
Frederik Barkhof | Wiesje M van der Flier | Philip Scheltens | Pieter Jelle Visser | W. M. van der Flier | P. Scheltens | F. Barkhof | P. Visser | B. Tijms | C. Teunissen | Mara Ten Kate | Charlotte E Teunissen | Betty M Tijms | M. ten Kate
[1] B. Boeve,et al. Does TDP-43 type confer a distinct pattern of atrophy in frontotemporal lobar degeneration? , 2010, Neurology.
[2] P. Grambsch,et al. Proportional hazards tests and diagnostics based on weighted residuals , 1994 .
[3] C. Jack,et al. Serial PIB and MRI in normal, mild cognitive impairment and Alzheimer's disease: implications for sequence of pathological events in Alzheimer's disease , 2009, Brain : a journal of neurology.
[4] M. Folstein,et al. Clinical diagnosis of Alzheimer's disease , 1984, Neurology.
[5] P. Vemuri,et al. Brain β-amyloid load approaches a plateau , 2013, Neurology.
[6] H. Braak,et al. Neuropathological stageing of Alzheimer-related changes , 2004, Acta Neuropathologica.
[7] Frederik Barkhof,et al. Optimizing patient care and research: the Amsterdam Dementia Cohort. , 2014, Journal of Alzheimer's disease : JAD.
[8] S Minoshima,et al. Diagnosis and management of dementia with Lewy bodies , 2005, Neurology.
[9] Charles D. Smith,et al. Hippocampal sclerosis of aging, a prevalent and high-morbidity brain disease , 2013, Acta Neuropathologica.
[10] John Suckling,et al. Global, voxel, and cluster tests, by theory and permutation, for a difference between two groups of structural MR images of the brain , 1999, IEEE Transactions on Medical Imaging.
[11] Li Shen,et al. Baseline MRI Predictors of Conversion from MCI to Probable AD in the ADNI Cohort , 2009, Current Alzheimer research.
[12] C. Jack,et al. 11C PiB and structural MRI provide complementary information in imaging of Alzheimer's disease and amnestic mild cognitive impairment. , 2008, Brain : a journal of neurology.
[13] C. Jack,et al. Antemortem MRI findings correlate with hippocampal neuropathology in typical aging and dementia , 2002, Neurology.
[14] A. Fagan,et al. Suspected non-Alzheimer disease pathophysiology — concept and controversy , 2016, Nature Reviews Neurology.
[15] R. Faber,et al. Frontotemporal lobar degeneration: a consensus on clinical diagnostic criteria. , 1999, Neurology.
[16] G. C. Román,et al. Vascular dementia , 1993, Neurology.
[17] C. Jack,et al. MRI and CSF biomarkers in normal, MCI, and AD subjects , 2009, Neurology.
[18] J. Hodges,et al. Outcome in subgroups of mild cognitive impairment (MCI) is highly predictable using a simple algorithm , 2009, Journal of Neurology.
[19] Nick C Fox,et al. Sensitivity of revised diagnostic criteria for the behavioural variant of frontotemporal dementia. , 2011, Brain : a journal of neurology.
[20] Clifford R. Jack,et al. Time-to-event voxel-based techniques to assess regional atrophy associated with MCI risk of progression to AD , 2011, NeuroImage.
[21] M. Freedman,et al. Frontotemporal lobar degeneration , 1998, Neurology.
[22] W. M. van der Flier,et al. Amyloid-beta(1-42), total tau, and phosphorylated tau as cerebrospinal fluid biomarkers for the diagnosis of Alzheimer disease. , 2010, Clinical chemistry.
[23] John Ashburner,et al. A fast diffeomorphic image registration algorithm , 2007, NeuroImage.
[24] C. Jack,et al. MRI patterns of atrophy associated with progression to AD in amnestic mild cognitive impairment , 2008, Neurology.
[25] Nick C Fox,et al. The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease , 2011 .
[26] Matthew L Senjem,et al. Different definitions of neurodegeneration produce similar amyloid/neurodegeneration biomarker group findings , 2015, Brain : a journal of neurology.
[27] W. M. van der Flier,et al. Concordance between cerebrospinal fluid biomarkers and [11C]PIB PET in a memory clinic cohort. , 2014, Journal of Alzheimer's disease : JAD.
[28] C. Jack,et al. Biomarker Modeling of Alzheimer’s Disease , 2013, Neuron.
[29] William Jagust,et al. Vulnerable Neural Systems and the Borderland of Brain Aging and Neurodegeneration , 2013, Neuron.
[30] E. Reiman,et al. Multicenter Standardized 18F-FDG PET Diagnosis of Mild Cognitive Impairment, Alzheimer's Disease, and Other Dementias , 2008, Journal of Nuclear Medicine.
[31] E. Tangalos,et al. Mild Cognitive Impairment Clinical Characterization and Outcome , 1999 .
[32] C. Rowe,et al. Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease , 2011, Annals of neurology.
[33] Dan Mungas,et al. Progression of mild cognitive impairment to dementia in clinic- vs community-based cohorts. , 2009, Archives of neurology.
[34] Bradford C. Dickerson,et al. Biomarker-based prediction of progression in MCI: Comparison of AD signature and hippocampal volume with spinal fluid amyloid-β and tau , 2013, Front. Aging Neurosci..
[35] Olivier Salvado,et al. Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer's disease: a voxelwise PiB-PET longitudinal study. , 2012, Brain : a journal of neurology.
[36] C. Rowe,et al. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study , 2013, The Lancet Neurology.
[37] Nick C Fox,et al. Amnestic Mild Cognitive Impairment: Structural MR Imaging Findings Predictive of Conversion to Alzheimer Disease , 2008, American Journal of Neuroradiology.
[38] Susan M Resnick,et al. Longitudinal patterns of β-amyloid deposition in nondemented older adults. , 2011, Archives of neurology.
[39] James T Becker,et al. Voxel Level Survival Analysis of Grey Matter Volume and Incident Mild Cognitive Impairment or Alzheimer's Disease. , 2015, Journal of Alzheimer's disease : JAD.
[40] Daniel Rueckert,et al. Injury markers predict time to dementia in subjects with MCI and amyloid pathology , 2012, Neurology.
[41] J. Trojanowski,et al. Integration and relative value of biomarkers for prediction of MCI to AD progression: Spatial patterns of brain atrophy, cognitive scores, APOE genotype and CSF biomarkers☆☆☆ , 2013, NeuroImage: Clinical.